IRadimed Corp expected to post earnings of 31  cents a share - Earnings Preview

IRADIMED

01/08/2023 19:33

* IRadimed Corp  IRMD.OQ   IRMD.O  is expected to show a
rise in
quarterly revenue when it reports  results on August 3. 
    * The Winter Springs Florida-based  company is expected to
report 
a 23.0% increase in revenue to $15.65 million from $12.72
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. The company's guidance on May
4 2023, for the period ended June 30, was for revenue between
$15.60 million and $15.80 million.
    * ​Refinitiv's mean analyst estimate for IRadimed Corp is
for
earnings of 31 cents per share. The company's EPS guidance on
May 4 2023, for the period ended June 30, was between $0.30 and
$0.32 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for IRadimed
Corp is
$55​, above​ its last closing price of $43.93. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  0.28        0.28       0.30      Beat    5.9
 Dec. 31 2023  0.30        0.30       0.32      Beat    6.7
 Sep. 30 2022  0.25        0.25       0.29      Beat    18.4​
 Jun. 30 2022  0.24        0.24       0.26      Beat    10.6
 ​​Mar.        0.21        0.21       0.22      Beat    7.3
 31 2022                                                
 Dec. 31 2021  0.21        0.21       0.33      Beat    57.1​
 Sep. 30 2021  0.17        0.17       0.23      Beat    35.3
 Jun. 30 2021  0.09        0.10       0.14      Beat    47.4
 This summary was machine generated August 1 at 18:33 GMT.  All
figures in US dollars  unless otherwise stated